INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2020

Nicotinamide riboside elevates NAD+ and shows therapeutic potential for metabolic, cardiovascular, neurodegenerative, and infectious disorders.

This review summarizes data on nicotinamide riboside (NR), an NAD+ precursor studied for its health benefits mediated through elevated NAD+ content. Evidence from animal and human studies indicates effectiveness in treating cardiovascular, neurodegenerative, and metabolic disorders, as well as emerging potential against pathogens such as SARS-CoV-2. The review also discusses challenges related to NR's bioavailability and safety, and compares it to other NAD+ precursors.

Study type
Narrative review
Who was studied
Human and animal studies
What was measured
Effects on metabolism, cardiovascular and neurodegenerative disorders, and infections

THE PAPER

Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.

Mehmel M, Jovanović N, Spitz U. Nutrients, 2020.

PubMed 32486488 ↗DOI 10.1007/s00394-019-01919-4 ↗

Heart & arteriesNutrients & adequacyBrain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.